Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis

Recent studies reported increased plasma glial acidic fibrillary protein (GFAP) levels in amyotrophic lateral sclerosis (ALS) patients compared to controls. We expanded these findings in a larger cohort, including 156 ALS patients and 48 controls, and investigated the associations of plasma GFAP wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrangelo, Andrea, Vacchiano, Veria, Zenesini, Corrado, Ruggeri, Edoardo, Baiardi, Simone, Cherici, Arianna, Avoni, Patrizia, Polischi, Barbara, Santoro, Francesca, Capellari, Sabina, Liguori, Rocco, Parchi, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531493/
https://www.ncbi.nlm.nih.gov/pubmed/37762278
http://dx.doi.org/10.3390/ijms241813976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531493/
https://www.ncbi.nlm.nih.gov/pubmed/37762278
http://dx.doi.org/10.3390/ijms241813976

Ejemplares similares